Ausgabe 7/2023
Inhalt (28 Artikel)
Plumbagin binds to epidermal growth factor receptor and mitigate the effects of epidermal growth factor micro-environment in PANC-1 cells
Loganayaki Periyasamy, Bharathi Murugantham, Sridhar Muthusami
Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC)
Nikhil Chandnani, Vedika Shrirang Choudhari, Rajat Talukdar, Sudeshna Rakshit, Geetha Shanmugam, Shiuli Guchait, Ishika Gupta, Melvin George, Koustav Sarkar
Investigation of the TLR4 and IRF3 signaling pathway-mediated effects of monensin in colorectal cancer cells
Mücahit Seçme, Sema Serter Kocoglu
Isorhamnetin exerts anti-tumor activity in DEN + CCl4-induced HCC mice
Sayanta Sarkar, Abhishek Kumar Das, Semantee Bhattacharya, Ratan Gachhui, Parames C. Sil
βcaryophyllene oxide induces apoptosis and inhibits proliferation of A549 lung cancer cells
Sameh M. Shabana, Nahla S. Gad, Azza I. Othman, Aly Fahmy Mohamed, Mohamed Amr El-Missiry
Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells
Haixia Wang, Junjie Zhou, Xiaoyu Ma, Changqing Jiao, Enbo Chen, Zhonghui Wu, Yan Zhang, Mengya Pan, Jianling Cui, Chengxin Luan, Jian Ge
A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
S. Verma, S. Chitikela, V. Singh, S. Khurana, D. Pushpam, D. Jain, S. Kumar, Y. Gupta, P. S. Malik
Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells
Riza Serttas, Suat Erdogan
In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer
Anuradha Sharma, Indu Sharma
Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle
Ecem Turkmen, Fatma Sogutlu, Mehmet Erdogan, Cigir Biray Avci
Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target
Sourat Darabi, Joanne Xiu, Timothy Samec, Santosh Kesari, Jose Carrillo, Sonikpreet Aulakh, Kyle M. Walsh, Soma Sengupta, Ashley Sumrall, David Spetzler, Michael Glantz, Michael J. Demeure
The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis
Maryam Rasouli, Sara Khakshournia, Omid Vakili, Sanaz Dastghaib, Atefeh Seghatoleslam, Sayed Mohammad Shafiee
Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study
Manyi Xu, Yue Hao, Huan Zhou, Zheng shi, Jinfei Si, Zhengbo Song
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer
Hina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, Suliman A. Alsagaby, Manzoor A. Mir
Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report
Abhishek Krishna, M. Sathya, S. Mukesh, M. S. Athiyamaan, Sourjya Banerjee, Johan Sunny, Challapalli Srinivas, Dilson Lobo, Bharat Sai Makkapatti, Vaishak Jawahar
Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)
Abdullah Mahmood Ali, Fatima BenMohamed, Alessandra Decina, Sanjay Mukherjee, Shelley Levi, Laura Nalleli Garrido Castillo, Davide Bréchot, Joseph Jurcic, Azra Raza, Patrizia Paterlini Bréchot
RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1
Adam Azlan, Kang Zi Khor, Yaashini Rajasegaran, Aliaa Arina Rosli, Mohamed Saifulaman Mohamed Said, Narazah Mohd Yusoff, Emmanuel Jairaj Moses
The application of radiofrequency ablation in pancreatic cancer liver-only recurrence after radical pancreatectomy
Chengfang Wang, Linjie Song, Zhijiang Wang, Weilin Wang
Racial and regional disparities in deaths in breast cancer
Akshita Khosla, Devashish Desai, Sachi Singhal, Aanchal Sawhney, Rashmika Potdar
Identification of glycogen phosphorylase L as a potential target for lung cancer
Xin-Ling He, Wen-Yu Lyu, Xin-Yuan Li, Hong Zhao, Lu Qi, Jin-Jian Lu
Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy
Simran Deep Kaur, Aman Deep Singh, Deepak N. Kapoor
The past, present, and future of immunotherapy for endometrial adenocarcinoma
Anna C. Jones, Karah H. Brown, Tianyun Guan, Luke A. Smith, Cole R. Formslag, Emerson D. Farjado, Qian Bai, Harrison D. Luechtefeld, Mark R. Wakefield, Lijun Dong, Yujiang Fang
Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis
Adyasha Bijay Mishra, Sudhansu Sekhar Nishank
Implications of IL-21 in solid tumor therapy
Seyed Hossein Abtahi Eivary, Ramiar Kamal Kheder, Soran K. Najmaldin, Nahid Kheradmand, Seyed-Alireza Esmaeili, Jafar Hajavi
Recent advancement of HDAC inhibitors against breast cancer
Syed Abdulla Mehmood, Kantrol Kumar Sahu, Sounok Sengupta, Sangh Partap, Rajshekhar Karpoormath, Brajesh Kumar, Deepak Kumar
The future of cancer immunotherapy: DNA vaccines leading the way
Aanshi Pandya, Yesha Shah, Nirjari Kothari, Humzah Postwala, Aayushi Shah, Priyajeet Parekh, Mehul R. Chorawala
NK cells direct the perspective approaches to cancer immunotherapy
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Farah A. Al-Marzook, Manar Mohammed Hizam, Sada Jasim Abdulameer, Abdul Kareem J. Al-Azzawi, Rahman S. Zabibah, Ali A. Fadhil
Current advances in microbial-based cancer therapies
Areej Shahbaz, Tehreem Mahmood, Muhammad Uzair Javed, Bilal Haider Abbasi